You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 5, 2024

CALCIUM GLUCONATE IN SODIUM CHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Calcium Gluconate In Sodium Chloride, and when can generic versions of Calcium Gluconate In Sodium Chloride launch?

Calcium Gluconate In Sodium Chloride is a drug marketed by Amneal, Fresenius Kabi Usa, and Hq Spclt Pharma. and is included in three NDAs. There are two patents protecting this drug.

The generic ingredient in CALCIUM GLUCONATE IN SODIUM CHLORIDE is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium Gluconate In Sodium Chloride

A generic version of CALCIUM GLUCONATE IN SODIUM CHLORIDE was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CALCIUM GLUCONATE IN SODIUM CHLORIDE?
  • What are the global sales for CALCIUM GLUCONATE IN SODIUM CHLORIDE?
  • What is Average Wholesale Price for CALCIUM GLUCONATE IN SODIUM CHLORIDE?
Summary for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Drug patent expirations by year for CALCIUM GLUCONATE IN SODIUM CHLORIDE
Recent Clinical Trials for CALCIUM GLUCONATE IN SODIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ascension Genesys HospitalPhase 2
Aurora Health CarePhase 4
First Affiliated Hospital Xi'an Jiaotong UniversityN/A

See all CALCIUM GLUCONATE IN SODIUM CHLORIDE clinical trials

Pharmacology for CALCIUM GLUCONATE IN SODIUM CHLORIDE

US Patents and Regulatory Information for CALCIUM GLUCONATE IN SODIUM CHLORIDE

CALCIUM GLUCONATE IN SODIUM CHLORIDE is protected by two US patents and one FDA Regulatory Exclusivity.

Patents protecting CALCIUM GLUCONATE IN SODIUM CHLORIDE

Calcium gluconate solutions in flexible containers
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Calcium gluconate solutions in flexible containers
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

FDA Regulatory Exclusivity protecting CALCIUM GLUCONATE IN SODIUM CHLORIDE

COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 217174-001 Sep 5, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-003 Jun 4, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Fresenius Kabi Usa CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 208418-005 Jun 17, 2021 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-003 Jun 4, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Amneal CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 217174-002 Sep 5, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 208418-004 Jun 17, 2021 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.